Financhill
Sell
18

HHS Quote, Financials, Valuation and Earnings

Last price:
$4.81
Seasonality move :
3.46%
Day range:
$4.44 - $4.90
52-week range:
$4.27 - $8.87
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.19x
P/B ratio:
1.63x
Volume:
21.7K
Avg. volume:
14.8K
1-year change:
-38.02%
Market cap:
$35.4M
Revenue:
$185.2M
EPS (TTM):
-$4.17

Earnings Data

Next earnings date for HHS
May 09
2025
Most recent earnings per share
-$0.33
Missed by $0.33
(Mar 17/2025)
Consensus Estimate
--
(Mar 17/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

HHS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/17/2025 Q4 -- $47.1M -$0.33 -- --
11/14/2024 Q3 $47.2M $47.6M $0.02 -- --
08/08/2024 Q2 -- $45M -$3.84 -- --
05/09/2024 Q1 -- $45.4M -$0.02 -- --
03/14/2024 Q4 $47M $49.5M -$0.27 $0.12 -$0.39
11/09/2023 Q3 $47.7M $47.1M $0.08 $0.18 -$0.10
08/10/2023 Q2 $49M $47.8M $0.08 $0.20 -$0.12
05/02/2023 Q1 $50.6M $47.1M -$0.11 $0.21 -$0.32
03/07/2023 Q4 $52.2M $54.8M $3.02 $0.10 $2.92
11/10/2022 Q3 $50.9M $53.9M $0.83 $0.41 $0.43
08/11/2022 Q2 $48.6M $48.6M $0.52 $0.32 $0.20
05/12/2022 Q1 -- $49.1M $0.39 -- --
02/24/2022 Q4 -- $52M $0.20 -- --
11/11/2021 Q3 -- $49.6M $0.52 -- --
06/30/2021 Q2 -- $49.3M $1.27 -- --
03/31/2021 Q1 -- $43.8M -$0.28 -- --
12/31/2020 Q4 -- $47.1M $0.11 -- --
09/30/2020 Q3 -- $47.7M -$0.27 -- --
06/30/2020 Q2 -- $41.6M -$0.99 -- --
03/31/2020 Q1 -- $40.5M $0.67 -- --
12/31/2019 Q4 -- $52.3M -$0.49 -- --
09/30/2019 Q3 -- $51.4M -$0.97 -- --
08/08/2019 Q2 -- $54.7M -$0.63 -- --
05/08/2019 Q1 -- $59.2M -$2.18 -- --
03/13/2019 Q4 -- $70.2M $0.20 -- --
11/07/2018 Q3 -- $63.6M -$1.62 -- --
08/08/2018 Q2 -- $69.6M -$1.10 -- --
05/09/2018 Q1 -- $81.2M $4.67 -- --
12/31/2017 Q4 -- $99.9M -$4.73 -- --
11/08/2017 Q3 -- $94.4M -$0.40 -- --
08/16/2017 Q2 -- $94.7M -$0.43 -- --
06/09/2017 Q1 -- $94.9M -$1.20 -- --
03/16/2017 Q4 -- $110.1M -$19.20 -- --
11/03/2016 Q3 -- $97.4M -$0.50 -- --
08/09/2016 Q2 -- $97.3M -$0.70 -- --
04/28/2016 Q1 -- $99.6M -$0.90 -- --
02/04/2016 Q4 -- $116.9M $0.40 -- --
11/03/2015 Q3 -- $108.8M -$27.70 -- --
07/30/2015 Q2 -- $109.2M -$0.70 -- --
04/30/2015 Q1 -- $121.2M $0.30 -- --

Harte-Hanks Earnings Questions

  • How Much did Harte-Hanks Generate in Revenue Last Quarter?

    Harte-Hanks reported $47.1M worth of top line sales in its most recent quarter.

  • Did Harte-Hanks Beat Earnings Last Quarter?

    Harte-Hanks announced earnings per share of -$0.33 which represents a miss of analyst forecast a -- per share.

  • Is Harte-Hanks Profitable?

    Harte-Hanks reported $32.3M that represents $4.40 per share over the last quarter.

  • What is the Analyst Consensus for Harte-Hanks EPS Next Year?

    Harte-Hanks's earnings are forecast to decrease from -$4.15 per share to $0.17 per share next year representing a decrease of -96.42%.

  • When is Harte-Hanks's Earnings Date?

    Harte-Hanks's next earnings date is May 9, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Tenable Stock a Buy, Sell or Hold?
Is Tenable Stock a Buy, Sell or Hold?

Tenable (NASDAQ:TENB) is a cybersecurity company with a focus on…

Is CyberArk Stock a Buy, Sell or Hold?
Is CyberArk Stock a Buy, Sell or Hold?

CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…

Is Amazon Stock Still Worth Staking On?
Is Amazon Stock Still Worth Staking On?

Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 24

Regencell Bioscience Holdings [RGC] is down 24.36% over the past day.

Buy
54
TNXP alert for Mar 24

Tonix Pharmaceuticals Holding [TNXP] is up 29.4% over the past day.

Sell
36
VMI alert for Mar 24

Valmont Industries [VMI] is up 3.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock